These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8486529

  • 1. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
    Takashi M, Sakata T, Kato K.
    Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
    Rasmuson T, Grankvist K, Ljungberg B.
    Cancer; 1993 Aug 15; 72(4):1324-8. PubMed ID: 8339221
    [Abstract] [Full Text] [Related]

  • 5. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
    Yaman O, Baltaci S, Arikan N, Ozdiler E, Göğüş O, Müftüoğlu YZ.
    Int Urol Nephrol; 1996 Aug 15; 28(2):207-10. PubMed ID: 8836790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of aldolase C isozyme in renal cell carcinoma.
    Takashi M, Haimoto H, Koshikawa T, Kato K.
    Am J Clin Pathol; 1990 May 15; 93(5):631-6. PubMed ID: 2183586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Serum gamma-enolase as a marker for renal cell carcinoma].
    Takashi M, Tanaka J, Mitsuya H, Murase T, Haimoto H, Kato K.
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb 15; 79(2):220-6. PubMed ID: 3225998
    [No Abstract] [Full Text] [Related]

  • 13. Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.
    Takashi M, Sakata T, Inaguma Y, Kato K.
    Urol Res; 1996 Feb 15; 24(6):375-9. PubMed ID: 9008332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
    Rasmuson T, Grankvist K, Roos G, Ljungberg B.
    Acta Oncol; 1999 Feb 15; 38(5):623-8. PubMed ID: 10427952
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.
    Ljungberg B, Rasmuson T, Grankvist K.
    Eur Urol; 1992 Feb 15; 21(2):160-3. PubMed ID: 1499617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.
    J Urol; 2008 Aug 15; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [Abstract] [Full Text] [Related]

  • 19. Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
    Ishiguro Y, Kato K, Ito T, Horisawa M, Nagaya M.
    Gan; 1984 Jan 15; 75(1):53-60. PubMed ID: 6327451
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.